分别应用腓骨单隧道重建及双隧道重建跟腓韧带与距腓前韧带的生物力学研究

注册号:

Registration number:

ChiCTR2400083396 

最近更新日期:

Date of Last Refreshed on:

2024-04-23 17:49:13 

注册时间:

Date of Registration:

2024-04-23 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

分别应用腓骨单隧道重建及双隧道重建跟腓韧带与距腓前韧带的生物力学研究

Public title:

Fibula single-tunnel versus fibula double-tunnel for both anterior talofibular ligament and calcaneofibular ligament reconstruction: a biomechanical comparison

注册题目简写:

English Acronym:

研究课题的正式科学名称:

分别应用腓骨单隧道重建及双隧道重建跟腓韧带与距腓前韧带的生物力学研究

Scientific title:

Fibula single-tunnel versus fibula double-tunnel for both anterior talofibular ligament and calcaneofibular ligament reconstruction: a biomechanical comparison

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

甘经岳 

研究负责人:

甘经岳 

Applicant:

Jingyue Gan 

Study leader:

Jingyue Gan 

申请注册联系人电话:

Applicant telephone:

+86 136 2408 6282

研究负责人电话:

Study leader's
telephone:

+86 136 2408 6282

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

bsagan.good@163.com

研究负责人电子邮件:

Study leader's E-mail:

bsagan.good@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

辽宁省大连市中山区三八广场8号 大连市友谊医院

研究负责人通讯地址:

辽宁省大连市中山区三八广场8号 大连市友谊医院

Applicant address:

Dalian Friendship Hospital, No.8 Sanba Square, Zhongshan District, Dalian City, Liaoning Province

Study leader's address:

Dalian Friendship Hospital, No.8 Sanba Square, Zhongshan District, Dalian City, Liaoning Province

申请注册联系人邮政编码:

Applicant postcode:

116001

研究负责人邮政编码:

Study leader's postcode:

116001

申请人所在单位:

大连市友谊医院

Applicant's institution:

Dalian Friendship Hospital

研究负责人所在单位:

大连市友谊医院

Affiliation of the Leader:

Dalian Friendship Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

YY-LL-2022-023

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

大连市友谊医院医学伦理委员会

Name of the ethic committee:

Dalian Friendship Hospital Medical Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2022-10-12 00:00:00

伦理委员会联系人:

郭军

Contact Name of the ethic committee:

Jun Guo

伦理委员会联系地址:

辽宁省大连市中山区三八广场8号 大连市友谊医院

Contact Address of the ethic committee:

Dalian Friendship Hospital, No.8 Sanba Square, Zhongshan District, Dalian City, Liaoning Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 411 8271 8822

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南方医科大学珠江医院

Primary sponsor:

Zhujiang Hospital of Southern Medical University

研究实施负责(组长)单位地址:

广东省广州市工业大道中253号

Primary sponsor's address:

253 Gongye Dadao Zhong, Guangzhou, Guangdong Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

辽宁省

市(区县):

大连市

Country:

China

Province:

Liaoning Province

City:

Dalian

单位(医院):

大连市友谊医院

具体地址:

辽宁省大连市中山区三八广场8号

Institution
hospital:

Dalian Friendship Hospital

Address:

No.8 Sanba Square, Zhongshan District, Dalian City, Liaoning Province

经费或物资来源:

国家自然科学基金(基金号:81974323)和广东省基础与应用基础研究基金(基金号:2022A1515011292)

Source(s) of funding:

National Natural Science Foundation of China, grant numbers 81974323 and Guangdong Basic and Applied Basic Research Foundation, grant numbers 2022A1515011292

研究疾病:

慢性踝关节不稳症  

Target disease:

Chronic ankle instability syndrom

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

临床治疗慢性踝关节不稳需要进行韧带重建者,目前有两种重建术式可供选择,一是应用腓骨单隧道重建距腓前韧带(anterior talofibular ligament,ATFL)及跟腓韧带(calcaneofibular ligament,CFL),一种是应用腓骨双隧道重建距腓前韧带及跟腓韧带,而两种方式的生物力学对比国内外均没有类似研究,本实验旨在比较两种方式在踝关节稳定性方面的差异及韧带最大失效强度和刚度方面的差异,从而为踝关节外侧副韧带损伤患者的韧带重建手术方式的选择提供生物力学依据,以指导临床应用。  

Objectives of Study:

In the cadaveric study, we performed both anterior talofibular ligament (ATFL) and calcaneofibular ligament (CFL) reconstruction by fibula single-tunnel technique and fibula double-tunnel technique, and compared the biomechanical differences between the two techniques.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

骨折、感染、肿瘤及解剖变异的踝关节标本

Exclusion criteria:

Ankle joint specimens with fractures, infections, tumors, and anatomic variations

研究实施时间:

Study execute time:

From 2022-09-05 00:00:00 To 2023-10-10 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-09-05 00:00:00 To 2022-10-05 00:00:00

干预措施:

Interventions:

组别:

A组:腓骨单隧道重建跟腓韧带和距腓前韧带

样本量:

6

Group:

Group A : fibular single-tunnel reconstruction of calcaneofibular and anterior talofibular ligaments

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

组别:

B组:腓骨双隧道重建跟腓韧带和距腓前韧带

样本量:

6

Group:

Group B: fibular double-tunnel reconstruction of calcaneofibular and anterior talofibular ligaments

Sample size:

干预措施:

干预措施代码:

Intervention:

NA

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

辽宁省 

市(区县):

 

Country:

China

Province:

Liaoning province

City:

单位(医院):

大连市友谊医院 

单位级别:

三甲 

Institution
hospital:

Dalian Friendship Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

辽宁省 

市(区县):

 

Country:

China

Province:

Liaoning province

City:

单位(医院):

南方医科大学珠江医院 

单位级别:

三甲 

Institution
hospital:

Zhujiang Hospital of Southern Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

距骨前移距离

指标类型:

主要指标

Outcome:

Anterior talar displacement, ATD

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

距骨倾斜角度

指标类型:

主要指标

Outcome:

Varus tilting angle,VTA

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

韧带最大失效强度

指标类型:

次要指标

Outcome:

Ultimate Failure Load

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

韧带刚度

指标类型:

次要指标

Outcome:

Stiffness

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

踝关节尸体标本

组织:

Sample Name:

Ankle cadaver specimen

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 31 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

none

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

公开原始数据日期:2025年1月1日;公开方式:上传到临床试验公共管理平台ResMan (www.medresman.org.cn)

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Public original data date: January 1, 2025; Disclosure method: Upload to ResMan (www.medrescman. org. cn), a public management platform for clinical trials

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-04-23 17:48:50